2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- PMID: 27751237
- DOI: 10.1016/j.jtcvs.2016.07.044
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Keywords: AHA; P2Y(12) inhibitor; Scientific Statements; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease.
Comment in
-
American College of Cardiology/American Heart Association 2016 dual antiplatelet therapy (DAPT) focused update: Implications for surgeons.J Thorac Cardiovasc Surg. 2016 Nov;152(5):1276-1278. doi: 10.1016/j.jtcvs.2016.04.047. Epub 2016 Apr 20. J Thorac Cardiovasc Surg. 2016. PMID: 27189892 No abstract available.
-
New guidelines on duration of dual antiplatelet therapy in patients with coronary artery disease: what's the novelty?J Thorac Dis. 2016 Oct;8(10):E1301-E1303. doi: 10.21037/jtd.2016.10.98. J Thorac Dis. 2016. PMID: 27867612 Free PMC article. No abstract available.
Similar articles
-
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2016 Sep 6;134(10):e156-78. doi: 10.1161/CIR.0000000000000405. Epub 2016 Mar 29. Circulation. 2016. PMID: 27026019 Review.
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29. Circulation. 2016. PMID: 27026020 Review. No abstract available.
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29. J Am Coll Cardiol. 2016. PMID: 27036918 No abstract available.
-
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Am Coll Cardiol. 2016 Sep 6;68(10):1116-39. doi: 10.1016/j.jacc.2016.03.512. Epub 2016 Mar 29. J Am Coll Cardiol. 2016. PMID: 27036919 Review.
-
ACC/AHA Versus ESC Guidelines on Dual Antiplatelet Therapy: JACC Guideline Comparison.J Am Coll Cardiol. 2018 Dec 11;72(23 Pt A):2915-2931. doi: 10.1016/j.jacc.2018.09.057. J Am Coll Cardiol. 2018. PMID: 30522654 Review.
Cited by
-
Heart Rate Variability and Coronary Artery Bypass Grafting: A Systematic Review.Rev Cardiovasc Med. 2024 Jan 22;25(1):36. doi: 10.31083/j.rcm2501036. eCollection 2024 Jan. Rev Cardiovasc Med. 2024. PMID: 39077663 Free PMC article.
-
A practical guide to the management of immune thrombocytopenia co-existing with acute coronary syndrome.Front Med (Lausanne). 2024 Apr 11;11:1348941. doi: 10.3389/fmed.2024.1348941. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38665297 Free PMC article. Review.
-
Global antiplatelet sales trend: A focus on P2Y12 inhibitors from 2008 to 2018.Am Heart J Plus. 2021 Jun 16;4:100020. doi: 10.1016/j.ahjo.2021.100020. eCollection 2021 Apr. Am Heart J Plus. 2021. PMID: 38559679 Free PMC article.
-
Effect of cytochrome P450 2C19 (CYP2C19) gene polymorphism and clopidogrel reactivity on long term prognosis of patients with coronary heart disease after PCI.J Geriatr Cardiol. 2024 Jan 28;21(1):90-103. doi: 10.26599/1671-5411.2024.01.004. J Geriatr Cardiol. 2024. PMID: 38440340 Free PMC article.
-
Impact of the reporting source on Platelet Inhibition and Treatment Outcomes (PLATO) trial deaths.Discoveries (Craiova). 2023 Sep 25;11(3):e174. doi: 10.15190/d.2023.13. eCollection 2023 Jul-Sep. Discoveries (Craiova). 2023. PMID: 38405426 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
